Target intelligence / Profile preview

BLK proto-oncogene, Src family tyrosine kinase (BLK)

Target
BLK
Molecular classification
Enzyme, Protein Kinase, Tyrosine Kinase, Src Family Kinase
01

Overview

BLK (B lymphocyte kinase) is a non-receptor tyrosine kinase belonging to the Src family of proto-oncogenes. It is primarily expressed in B-lineage cells and plays a significant role in B-cell receptor (BCR) signaling and B-cell development. The protein encoded by the BLK gene is involved in cell proliferation and differentiation, particularly within the immune system. Activation of BLK leads to downstream phosphorylation events that are critical for further signal propagation within the cell. While direct disease associations specific to BLK mutations or dysregulation remain less well characterized compared with some other Src-family members, aberrant activity or altered expression could theoretically contribute to disorders involving abnormal proliferation/differentiation of lymphoid lineages.

Other names
B lymphocyte kinasep55-Blk
02

Mechanism of action

Kinase inhibition (potential, not explicitly stated for specific BLK inhibitors in the text, but inferred from general Src family kinase targeting)

03

Biological functions

Signal transductionCell proliferationCell differentiationImmune responseB-cell receptor (BCR) signalingB-cell development
04

Disease associations

CancerAutoimmune disordersLymphoproliferative disorders
05

Safety considerations

Potential for off-target effects due to similarity with other Src family kinasesPossible disruption of normal B-cell development and function

Beyond the preview

Go deeper on BLK proto-oncogene, Src family tyrosine kinase (BLK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BLK proto-oncogene, Src family tyrosine kinase (BLK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call